134 related articles for article (PubMed ID: 6464979)
1. Long-term beneficial effect of nifedipine in primary pulmonary hypertension.
Lunde P; Rasmussen K
Am Heart J; 1984 Aug; 108(2):415-6. PubMed ID: 6464979
[No Abstract] [Full Text] [Related]
2. Nifedipine reduces pulmonary pressure and vascular tone during short- but not long-term treatment of pulmonary hypertension in patients with chronic obstructive pulmonary disease.
Agostoni P; Doria E; Galli C; Tamborini G; Guazzi MD
Am Rev Respir Dis; 1989 Jan; 139(1):120-5. PubMed ID: 2912331
[TBL] [Abstract][Full Text] [Related]
3. Hemodynamic effects of nifedipine on secondary pulmonary hypertension in man.
Garzaniti N; el Allaf D; D'Orio V; Cremers S; Marcelle R; Carlier J
Acta Cardiol; 1985; 40(2):207-15. PubMed ID: 3873156
[TBL] [Abstract][Full Text] [Related]
4. Comparative effects of nifedipine, verapamil, and diltiazem on experimental pulmonary hypertension.
Young TE; Lundquist LJ; Chesler E; Weir EK
Am J Cardiol; 1983 Jan; 51(1):195-200. PubMed ID: 6571766
[TBL] [Abstract][Full Text] [Related]
5. Nifedipine attenuates acute hypoxic pulmonary vasoconstriction in patients with chronic obstructive pulmonary disease.
Burghuber OC
Respiration; 1987; 52(2):86-93. PubMed ID: 3671896
[TBL] [Abstract][Full Text] [Related]
6. Adverse effect of hydralazine in patients with primary pulmonary hypertension.
Kronzon I; Cohen M; Winer HE
JAMA; 1982 Jun; 247(22):3112-4. PubMed ID: 7077805
[No Abstract] [Full Text] [Related]
7. Effect of nifedipine on physiologic shunting and oxygenation in chronic obstructive pulmonary disease.
Kalra L; Bone MF
Am J Med; 1993 Apr; 94(4):419-23. PubMed ID: 8475936
[TBL] [Abstract][Full Text] [Related]
8. Hemodynamic effects of nifedipine versus hydralazine in primary pulmonary hypertension.
Fisher J; Borer JS; Moses JW; Goldberg HL; Niarchos AP; Whitman HH; Mermelstein M
Am J Cardiol; 1984 Sep; 54(6):646-50. PubMed ID: 6475787
[TBL] [Abstract][Full Text] [Related]
9. Acute and long-term effects of nifedipine on pulmonary and systemic hemodynamics in patients with pulmonary hypertension associated with diffuse systemic sclerosis, the CREST syndrome and mixed connective tissue disease.
Alpert MA; Pressly TA; Mukerji V; Lambert CR; Mukerji B; Panayiotou H; Sharp GC
Am J Cardiol; 1991 Dec; 68(17):1687-91. PubMed ID: 1746473
[TBL] [Abstract][Full Text] [Related]
10. Comparative actions of hydralazine, nifedipine and amrinone in primary pulmonary hypertension.
Rich S; Ganz R; Levy PS
Am J Cardiol; 1983 Nov; 52(8):1104-7. PubMed ID: 6637831
[TBL] [Abstract][Full Text] [Related]
11. [Variable hemodynamic response to nifedipine in pulmonary hypertension secondary to chronic obstructive bronchopathy and pulmonary fibrosis].
Domenighetti G
Schweiz Med Wochenschr; 1985 Sep; 115(39):1345-7. PubMed ID: 4071009
[TBL] [Abstract][Full Text] [Related]
12. Cardiovascular effects of vasodilator therapy for pulmonary arterial hypertension.
Rubin LJ
Clin Chest Med; 1983 May; 4(2):309-19. PubMed ID: 6342925
[No Abstract] [Full Text] [Related]
13. Acute nonhemodynamic pulmonary edema with nifedipine in primary pulmonary hypertension.
Prigogine T; Waterlot Y; Gottignies P; Verhoeven A; Decroly P
Chest; 1991 Aug; 100(2):563-4. PubMed ID: 1864141
[TBL] [Abstract][Full Text] [Related]
14. [Primary pulmonary hypertension in childhood: the positive long-term therapeutic effect of nifedipine (Corinfar)].
Köhler W; von Jan V; Schmidt H
Kinderarztl Prax; 1987 Nov; 55(11):549-58. PubMed ID: 3126337
[No Abstract] [Full Text] [Related]
15. Pulmonary hypertension in systemic lupus erythematosus.
Gladman DD; Sternberg L
J Rheumatol; 1985 Apr; 12(2):365-7. PubMed ID: 4032410
[TBL] [Abstract][Full Text] [Related]
16. The effect of levarterenol and phentolamine on the hypertensive pulmonary vasculature.
Rhodes EL; O'Rourke PT; Lee R; Straker J; Kirsh MM
Ann Thorac Surg; 1973 Oct; 16(4):375-9. PubMed ID: 4746618
[No Abstract] [Full Text] [Related]
17. Paradoxical elevation of pulmonary vascular resistance after nifedipine in primary pulmonary hypertension. A case study.
Pohar B; Grad A; Mozina M; Rakovec P; Horvat M
Cor Vasa; 1989; 31(3):238-41. PubMed ID: 2766755
[TBL] [Abstract][Full Text] [Related]
18. Pharmacologically induced pulmonary vasodilatation in children and young adults with primary pulmonary hypertension.
Barst RJ
Chest; 1986 Apr; 89(4):497-503. PubMed ID: 2869919
[TBL] [Abstract][Full Text] [Related]
19. Hemodynamic effects of nifedipine in primary pulmonary hypertension.
Douglas JS
J Am Coll Cardiol; 1983 Jul; 2(1):174-9. PubMed ID: 6853910
[TBL] [Abstract][Full Text] [Related]
20. Long-term treatment of primary pulmonary hypertension with continuous intravenous epoprostenol (prostacyclin).
Higenbottam T; Wheeldon D; Wells F; Wallwork J
Lancet; 1984 May; 1(8385):1046-7. PubMed ID: 6143976
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
